Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial
- PMID: 2140987
- DOI: 10.1016/s0950-821x(05)80427-x
Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial
Abstract
Percutaneous transluminal angioplasty (PTA) is a commonly performed procedure for the treatment of intermittent claudication despite the lack of controlled studies. The aim of this study was to compare PTA with supervised exercise therapy for patients with arterial occlusive disease judged suitable for PTA at angiography. Patients were assessed before treatment commenced and at three monthly intervals afterwards. Assessment included measurement of resting ankle brachial pressure indices (ABPI), and claudicating and maximum walking distances on a treadmill up a 10 degrees incline. Twenty patients were randomised to receive PTA and 16 exercise. The groups were similar in age, sex, smoking habits and arteriographic pattern of disease. In the PTA group two patients had angioplasties that were technically unsuccessful and two other patients subsequently required surgery. One patient in the exercise group subsequently had a PTA. After PTA, mean ABPI were significantly improved at 3, 6 and 9 months (P less than 0.01) without a corresponding significant increase in mean maximum walking distances. However in the exercise group despite no increase in mean ABPI, mean maximum walking distances increased progressively, with significant increases at 6, 9 and 12 months (P less than 0.01).
Similar articles
-
The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease.Eur J Vasc Endovasc Surg. 2008 Dec;36(6):680-8. doi: 10.1016/j.ejvs.2008.10.007. Eur J Vasc Endovasc Surg. 2008. PMID: 19022184 Clinical Trial.
-
Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial.J Vasc Surg. 1997 Oct;26(4):551-7. doi: 10.1016/s0741-5214(97)70052-1. J Vasc Surg. 1997. PMID: 9357454 Clinical Trial.
-
Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial.Eur J Vasc Endovasc Surg. 1996 May;11(4):409-13. doi: 10.1016/s1078-5884(96)80171-7. Eur J Vasc Endovasc Surg. 1996. PMID: 8846172 Clinical Trial.
-
Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients.Ann Vasc Surg. 2010 May;24(4):498-502. doi: 10.1016/j.avsg.2009.08.013. Epub 2009 Dec 29. Ann Vasc Surg. 2010. PMID: 20036508 Review.
-
Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease.Vascular. 2006 Mar-Apr;14(2):81-7. doi: 10.2310/6670.2006.00017. Vascular. 2006. PMID: 16956476 Review.
Cited by
-
Treatment of specific macrovascular beds in patients with diabetes mellitus.Osteopath Med Prim Care. 2010 Aug 11;4:5. doi: 10.1186/1750-4732-4-5. Osteopath Med Prim Care. 2010. PMID: 20701768 Free PMC article.
-
Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.Pharmacoeconomics. 2002;20(3):169-81. doi: 10.2165/00019053-200220030-00003. Pharmacoeconomics. 2002. PMID: 11929347
-
Behaviour change interventions to promote physical activity in people with intermittent claudication: the OPTIMA systematic review.Health Technol Assess. 2025 May;29(18):1-142. doi: 10.3310/ZBNG5240. Health Technol Assess. 2025. PMID: 40421965 Free PMC article.
-
Endovascular revascularisation versus conservative management for intermittent claudication.Cochrane Database Syst Rev. 2018 Mar 8;3(3):CD010512. doi: 10.1002/14651858.CD010512.pub2. Cochrane Database Syst Rev. 2018. PMID: 29518253 Free PMC article.
-
Pentoxifylline in arterial disease of the legs.Eur J Clin Pharmacol. 1991;41(6):507-9. doi: 10.1007/BF00314975. Eur J Clin Pharmacol. 1991. PMID: 1815961 No abstract available.